212 related articles for article (PubMed ID: 23186030)
1. Community perceptions of malaria and vaccines in two districts of Mozambique.
Bingham A; Gaspar F; Lancaster K; Conjera J; Collymore Y; Ba-Nguz A
Malar J; 2012 Nov; 11():394. PubMed ID: 23186030
[TBL] [Abstract][Full Text] [Related]
2. Community perceptions of malaria and vaccines in the South Coast and Busia regions of Kenya.
Ojakaa DI; Ofware P; Machira YW; Yamo E; Collymore Y; Ba-Nguz A; Vansadia P; Bingham A
Malar J; 2011 May; 10():147. PubMed ID: 21624117
[TBL] [Abstract][Full Text] [Related]
3. Community perceptions of a malaria vaccine in the Kintampo districts of Ghana.
Febir LG; Asante KP; Dzorgbo DB; Senah KA; Letsa TS; Owusu-Agyei S
Malar J; 2013 May; 12():156. PubMed ID: 23651533
[TBL] [Abstract][Full Text] [Related]
4. Community perceptions on the secondary health benefits established by malaria vaccine trials (RTS,S phase 2 and phase 3) at the Korogwe site in North Eastern Tanzania.
Liheluka EA; Lusingu JP; Manongi RN
Malar J; 2013 May; 12():157. PubMed ID: 23651535
[TBL] [Abstract][Full Text] [Related]
5. Factors likely to affect community acceptance of a malaria vaccine in two districts of Ghana: a qualitative study.
Meñaca A; Tagbor H; Adjei R; Bart-Plange C; Collymore Y; Ba-Nguz A; Mertes K; Bingham A
PLoS One; 2014; 9(10):e109707. PubMed ID: 25334094
[TBL] [Abstract][Full Text] [Related]
6. Perceptions of malaria and vaccines in Kenya.
Ojakaa D; Yamo E; Collymore Y; Ba-Nguz A; Bingham A
Hum Vaccin; 2011 Oct; 7(10):1096-9. PubMed ID: 21941095
[TBL] [Abstract][Full Text] [Related]
7. Community knowledge and acceptance of indoor residual spraying for malaria prevention in Mozambique: a qualitative study.
Magaço A; Botão C; Nhassengo P; Saide M; Ubisse A; Chicumbe S; Zulliger R
Malar J; 2019 Jan; 18(1):27. PubMed ID: 30683091
[TBL] [Abstract][Full Text] [Related]
8. Stakeholders' opinions and questions regarding the anticipated malaria vaccine in Tanzania.
Mtenga S; Kimweri A; Romore I; Ali A; Exavery A; Sicuri E; Tanner M; Abdulla S; Lusingu J; Kafuruki S
Malar J; 2016 Apr; 15():189. PubMed ID: 27048260
[TBL] [Abstract][Full Text] [Related]
9. Caregiver and community perceptions and experiences participating in an infant malaria prevention trial of PfSPZ Vaccine administered by direct venous inoculation: a qualitative study in Siaya County, western Kenya.
Achieng F; Rosen JG; Cherop RY; Kariuki S; Hoffman SL; Seder R; Oneko M; Steinhardt LC
Malar J; 2020 Jun; 19(1):226. PubMed ID: 32580719
[TBL] [Abstract][Full Text] [Related]
10. Acceptance of a malaria vaccine by caregivers of sick children in Kenya.
Ojakaa DI; Jarvis JD; Matilu MI; Thiam S
Malar J; 2014 May; 13():172. PubMed ID: 24886650
[TBL] [Abstract][Full Text] [Related]
11. Examining community perceptions of malaria to inform elimination efforts in Southern Mozambique: a qualitative study.
Portugaliza HP; Galatas B; Nhantumbo H; Djive H; Murato I; Saúte F; Aide P; Pell C; Munguambe K
Malar J; 2019 Jul; 18(1):232. PubMed ID: 31296238
[TBL] [Abstract][Full Text] [Related]
12. Parents' and informal caregivers' views and experiences of communication about routine childhood vaccination: a synthesis of qualitative evidence.
Ames HM; Glenton C; Lewin S
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD011787. PubMed ID: 28169420
[TBL] [Abstract][Full Text] [Related]
13. Are we interconnected? A qualitative study on the role and perception of different actors on malaria social behaviour change interventions in rural Mozambique.
de Sousa Pinto da Fonseca L; Arroz JAH; do Rosário O Martins M; Hartz Z
Malar J; 2020 Nov; 19(1):420. PubMed ID: 33228658
[TBL] [Abstract][Full Text] [Related]
14. Are malaria transmission-blocking vaccines acceptable to high burden communities? Results from a mixed methods study in Bo, Sierra Leone.
McCoy KD; Weldon CT; Ansumana R; Lamin JM; Stenger DA; Ryan SJ; Bardosh K; Jacobsen KH; Dinglasan RR
Malar J; 2021 Apr; 20(1):183. PubMed ID: 33849572
[TBL] [Abstract][Full Text] [Related]
15. What drives community adherence to indoor residual spraying (IRS) against malaria in Manhiça district, rural Mozambique: a qualitative study.
Munguambe K; Pool R; Montgomery C; Bavo C; Nhacolo A; Fiosse L; Sacoor C; Nhalungo D; Mabunda S; Macete E; Alonso P
Malar J; 2011 Nov; 10():344. PubMed ID: 22111698
[TBL] [Abstract][Full Text] [Related]
16. Caregivers' perception and acceptance of malaria vaccine for Children.
Bam V; Mohammed A; Kusi-Amponsah A; Armah J; Lomotey AY; Budu HI; Atta Poku C; Kyei-Dompim J; Dwumfour C
PLoS One; 2023; 18(7):e0288686. PubMed ID: 37494408
[TBL] [Abstract][Full Text] [Related]
17. Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial.
Aponte JJ; Aide P; Renom M; Mandomando I; Bassat Q; Sacarlal J; Manaca MN; Lafuente S; Barbosa A; Leach A; Lievens M; Vekemans J; Sigauque B; Dubois MC; Demoitié MA; Sillman M; Savarese B; McNeil JG; Macete E; Ballou WR; Cohen J; Alonso PL
Lancet; 2007 Nov; 370(9598):1543-51. PubMed ID: 17949807
[TBL] [Abstract][Full Text] [Related]
18. The acceptability of intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in southern Tanzania.
Pool R; Mushi A; Schellenberg JA; Mrisho M; Alonso P; Montgomery C; Tanner M; Mshinda H; Schellenberg D
Malar J; 2008 Oct; 7():213. PubMed ID: 18939971
[TBL] [Abstract][Full Text] [Related]
19. Knowledge, attitudes, and beliefs of school nurses and personnel and associations with nonmedical immunization exemptions.
Salmon DA; Moulton LH; Omer SB; Chace LM; Klassen A; Talebian P; Halsey NA
Pediatrics; 2004 Jun; 113(6):e552-9. PubMed ID: 15173536
[TBL] [Abstract][Full Text] [Related]
20. Malaria vaccine development: an endemic country perspective.
Koram KA; Gyan BA
Hum Vaccin; 2010 Jan; 6(1):12-6. PubMed ID: 19806020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
